Видео ютуба по тегу European Leukemianet

European LeukemiaNet 2017 AML recommendations: impact on risk stratification and survival
European LeukemiaNet 2017 AML recommendations: impact on risk stratification and survival
European LeukemiaNet (ELN) 2020 recommendations for treating chronic myeloid leukemia incl. Q&A ...
European LeukemiaNet (ELN) 2020 recommendations for treating chronic myeloid leukemia incl. Q&A ...
2025 ELN Recommendations on the Management of CML
2025 ELN Recommendations on the Management of CML
The AML Global Portal
The AML Global Portal
Validating the ELN genetic risk classification in patients with AML treated with aza-ven
Validating the ELN genetic risk classification in patients with AML treated with aza-ven
The role of MRD status & the ELN 2022 in predicting clinical outcomes of patients with AML
The role of MRD status & the ELN 2022 in predicting clinical outcomes of patients with AML
AML risk stratification
AML risk stratification
Impact of MMRD and ELN genetic classification in outcomes for patients with AML underoging alloHCT
Impact of MMRD and ELN genetic classification in outcomes for patients with AML underoging alloHCT
Validation of 2022 diagnostic & prognostic classifications of AML
Validation of 2022 diagnostic & prognostic classifications of AML
What is the optimal gene panel to be assessed for risk stratification?
What is the optimal gene panel to be assessed for risk stratification?
Impact of ASXL1 mutations in favorable risk AML treated with ven-containing low-intensity therapy
Impact of ASXL1 mutations in favorable risk AML treated with ven-containing low-intensity therapy
Refining the 2022 ELN guidelines for AML risk stratification using machine learning
Refining the 2022 ELN guidelines for AML risk stratification using machine learning
The role of whole exome sequencing in AML and the importance of molecular genetics
The role of whole exome sequencing in AML and the importance of molecular genetics
What do long term data from the VIALE A trial tell us about treatment with azacitidine + venetoclax?
What do long term data from the VIALE A trial tell us about treatment with azacitidine + venetoclax?
Novel classification system to improve post-transplant AML prognosis
Novel classification system to improve post-transplant AML prognosis
MRD in AML: ELN recommendations
MRD in AML: ELN recommendations
Dr Susanne Saussele Defines When Patients With CML Should Change Therapy
Dr Susanne Saussele Defines When Patients With CML Should Change Therapy
The standardization of flow cytometry
The standardization of flow cytometry
Does the mutational profile impact outcomes following transplant?
Does the mutational profile impact outcomes following transplant?
Разделы
Разделы "Онкогематология"